PUT - SPRINTER OPEN END - BIOGEN IDEC | Delayed Deutsche Boerse AG 10:52:54 2024-06-04 EDT | ||
| 9.43 EUR | -1.57% |
|
| Current month | -5.99% | ||
| 1 month | -12.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 9.43 | -1.57% |
| 24-06-03 | 9.58 | -5.99% |
| 24-05-31 | 10.19 | -5.12% |
| 24-05-30 | 10.74 | -3.07% |
| 24-05-29 | 11.08 | +2.21% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 10:52 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV7EKK |
| ISIN | DE000VV7EKK2 |
| Date issued | 2022-09-29 |
| Strike | 332.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.99 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.47 € |
|---|---|
| Lowest since issue | 1.01 € |
| Spread | 0.03 € |
| Spread % | 0.31% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
229.8
USD
Average target price
284.8
USD
Spread / Average Target
+23.93%
- Stock Market
- Certificates
- Certificat
